145 related articles for article (PubMed ID: 21196843)
1. Analysis of a possible association between oral lichen planus and drug intake. A controlled study.
Hirota SK; Moreno RA; dos Santos CH; Seo J; Migliari DA
Med Oral Patol Oral Cir Bucal; 2011 Sep; 16(6):e750-6. PubMed ID: 21196843
[TBL] [Abstract][Full Text] [Related]
2. Oral lichen planus and intake of drugs metabolized by polymorphic cytochrome P450 enzymes.
Kragelund C; Thomsen CE; Bardow A; Pedersen AM; Nauntofte B; Reibel J; Torpet LA
Oral Dis; 2003 Jul; 9(4):177-87. PubMed ID: 12974517
[TBL] [Abstract][Full Text] [Related]
3. Medication use and medical history of 155 patients with oral lichenoid lesions: a retrospective study.
Alqahtani M; Woods TR; Smith MH; Bhattacharyya I; Cohen DM; Islam MN; Fitzpatrick SG
Gen Dent; 2018; 66(2):40-45. PubMed ID: 29513234
[TBL] [Abstract][Full Text] [Related]
4. Use of systemic medication in patients with oral lichen planus - a possible association with hypothyroidism.
Robledo-Sierra J; Mattsson U; Jontell M
Oral Dis; 2013 Apr; 19(3):313-9. PubMed ID: 22943671
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P450 2D6 polymorphism and drug utilization in patients with oral lichen planus.
Paulusová V; Rösch C; Drízhal I; Perlík F; Masín V; Sukumar S; Slezák R; Slanar O
Acta Odontol Scand; 2010 Jul; 68(4):193-8. PubMed ID: 20201714
[TBL] [Abstract][Full Text] [Related]
6. Can the genotype or phenotype of two polymorphic drug metabolising cytochrome P450-enzymes identify oral lichenoid drug eruptions?
Kragelund C; Hansen C; Reibel J; Nauntofte B; Brosen K; Jensen SB; Torpet LA
J Oral Pathol Med; 2010 Jul; 39(6):497-505. PubMed ID: 20492431
[TBL] [Abstract][Full Text] [Related]
7. A Novel Approach to Differentiating Erosive and Reticular Lichen Planus Based on the Percentage of Dental Surfaces With Metal Restorations.
Zisis V; Giannakopoulos NN; Schmitter M; Poulopoulos A; Andreadis D
Cureus; 2023 Sep; 15(9):e44782. PubMed ID: 37809260
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of prolidase activity and oxidative stress in patients with oral lichen planus and oral lichenoid contact reactions.
Batu Ş; Ofluoğlu D; Ergun S; Warnakulasuriya S; Uslu E; Güven Y; Tanyeri H
J Oral Pathol Med; 2016 Apr; 45(4):281-8. PubMed ID: 26661727
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of micronuclear frequencies in both circulating lymphocytes and buccal epithelial cells of patients with oral lichen planus and oral lichenoid contact reactions.
Saruhanoğlu A; Ergun S; Kaya M; Warnakulasuriya S; Erbağcı M; Öztürk Ş; Deniz E; Özel S; Çefle K; Palanduz Ş; Tanyeri H
Oral Dis; 2014 Jul; 20(5):521-7. PubMed ID: 24033885
[TBL] [Abstract][Full Text] [Related]
10. The significance of oral and systemic factors in Australian and Croatian patients with oral lichen planus.
Vučićević Boras V; Savage NW; Brailo V; Škrinjar I; Valter K; Alajbeg I; Dulčić N; Vidović Juras D
Acta Dermatovenerol Croat; 2014; 22(2):97-102. PubMed ID: 25102794
[TBL] [Abstract][Full Text] [Related]
11. A clinical study of 674 patients with oral lichen planus in China.
Xue JL; Fan MW; Wang SZ; Chen XM; Li Y; Wang L
J Oral Pathol Med; 2005 Sep; 34(8):467-72. PubMed ID: 16091113
[TBL] [Abstract][Full Text] [Related]
12. [Potentially malignant character of oral lichen planus and lichenoid lesions].
Mares S; Ben Slama L; Gruffaz F; Goudot P; Bertolus C
Rev Stomatol Chir Maxillofac Chir Orale; 2013 Nov; 114(5):293-8. PubMed ID: 23849797
[TBL] [Abstract][Full Text] [Related]
13. Filaggrin gene mutations and the distribution of filaggrin in oral mucosa of patients with oral lichen planus and healthy controls.
Larsen KR; Johansen JD; Reibel J; Zachariae C; Rosing K; Pedersen AML
J Eur Acad Dermatol Venereol; 2017 May; 31(5):887-893. PubMed ID: 28000306
[TBL] [Abstract][Full Text] [Related]
14. The effect of antiresorptive therapy on the prevalence and severity of oral lichen planus: a retrospective study.
Parvini P; Obreja K; Cafferata EA; Aini T; Lermen Y; Begic A; Sader R; Schwarz F
BMC Oral Health; 2024 May; 24(1):547. PubMed ID: 38730315
[TBL] [Abstract][Full Text] [Related]
15. Gingival involvement of oral lichen planus in a series of 700 patients.
Mignogna MD; Lo Russo L; Fedele S
J Clin Periodontol; 2005 Oct; 32(10):1029-33. PubMed ID: 16174264
[TBL] [Abstract][Full Text] [Related]
16. Oral lichen planus and oral lichenoid lesions: diagnostic and therapeutic considerations.
Al-Hashimi I; Schifter M; Lockhart PB; Wray D; Brennan M; Migliorati CA; Axéll T; Bruce AJ; Carpenter W; Eisenberg E; Epstein JB; Holmstrup P; Jontell M; Lozada-Nur F; Nair R; Silverman B; Thongprasom K; Thornhill M; Warnakulasuriya S; van der Waal I
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103 Suppl():S25.e1-12. PubMed ID: 17261375
[TBL] [Abstract][Full Text] [Related]
17. Oral lichenoid lesions and serum antinuclear antibodies in Thai patients.
Prucktrakul C; Youngnak-Piboonratanakit P; Kanjanabuch P; Prueksrisakul T; Thongprasom K
J Oral Pathol Med; 2015 Jul; 44(6):468-74. PubMed ID: 25213373
[TBL] [Abstract][Full Text] [Related]
18. Is oral cancer incidence among patients with oral lichen planus/oral lichenoid lesions underestimated?
Gonzalez-Moles MA; Gil-Montoya JA; Ruiz-Avila I; Bravo M
J Oral Pathol Med; 2017 Feb; 46(2):148-153. PubMed ID: 27426232
[TBL] [Abstract][Full Text] [Related]
19. Unstimulated whole salivary flow rate and anxiolytics intake are independently associated with oral Candida infection in patients with oral lichen planus.
Bokor-Bratic M; Cankovic M; Dragnic N
Eur J Oral Sci; 2013 Oct; 121(5):427-33. PubMed ID: 24028590
[TBL] [Abstract][Full Text] [Related]
20. Oral lichen planus and thyroid gland diseases: possible associations.
Kats L; Goldman Y; Kahn A; Goldman V; Gorsky M
BMC Oral Health; 2019 Jul; 19(1):169. PubMed ID: 31366342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
